Matinas Biopharma Holdings, Inc. (MTNB): Price and Financial Metrics


Matinas Biopharma Holdings, Inc. (MTNB): $0.59

0.00 (-0.10%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MTNB to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

MTNB Stock Price Chart Interactive Chart >

Price chart for MTNB

MTNB Price/Volume Stats

Current price $0.59 52-week high $1.00
Prev. close $0.59 52-week low $0.43
Day low $0.57 Volume 237,142
Day high $0.60 Avg. volume 278,728
50-day MA $0.59 Dividend yield N/A
200-day MA $0.72 Market Cap 127.82M

Matinas Biopharma Holdings, Inc. (MTNB) Company Bio


Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing therapeutics for the treatment of fungal and bacterial infections.


MTNB Latest News Stream


Event/Time News Detail
Loading, please wait...

MTNB Latest Social Stream


Loading social stream, please wait...

View Full MTNB Social Stream

Latest MTNB News From Around the Web

Below are the latest news stories about MATINAS BIOPHARMA HOLDINGS INC that investors may wish to consider to help them evaluate MTNB as an investment opportunity.

Matinas BioPharma to Provide Corporate Update and 2023 Business Outlook on January 30, 2023

Conference call and live audio webcast scheduled for Monday, January 30th at 4:30 p.m. ETBEDMINSTER, N.J., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology, today announced that the Company will host a conference call and live audio webcast on Monday, January 30, 2023 at 4:30 p.m. ET to provide

Yahoo | January 23, 2023

12 Hot Penny Stocks On the Rise

In this article, we discuss 12 hot penny stocks on the rise. If you want to see more stocks in this selection, check out 5 Hot Penny Stocks On the Rise. Penny stocks usually trade under $5 and are favored by new investors or market participants who prefer day trading. Some key indicators that penny […]

Yahoo | January 20, 2023

Matinas BioPharma Announces Collaboration with National Resilience to Explore and Evaluate Novel LNC Platform Delivery Technology for Certain Nucleic Acids

BEDMINSTER, N.J., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology, today announced a strategic collaboration with National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to complex medicines. The parties have entered into a Material Tran

Yahoo | January 12, 2023

Matinas BioPharma Holdings Inc. (AMEX: MTNB) Stock Forecast: By 2022, Bulls Expect $3.00 Per Share

In the last trading session, 1.11 million shares of the Matinas BioPharma Holdings Inc. (AMEX:MTNB) were traded, and its beta was 1.96. Most recently the company’s share price was $0.52, and it changed around $0.02 or 3.74% from the last close, which brings the market valuation of the company to $108.50M. MTNB currently trades at … Matinas BioPharma Holdings Inc. (AMEX: MTNB) Stock Forecast: By 2022, Bulls Expect $3.00 Per Share Read More »

Marketing Sentinel | December 27, 2022

How did Matinas BioPharma Holdings Inc. (MTNB) fare last session?

As of Tuesday, Matinas BioPharma Holdings Inc.’s (AMEX:MTNB) stock closed at $0.57, down from $0.61 the previous day. While Matinas BioPharma Holdings Inc. has underperformed by -6.56%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MTNB fell by -42.82%, with highs and lows ranging from $1.16 […]

US Post News | December 7, 2022

Read More 'MTNB' Stories Here

MTNB Price Returns

1-mo 26.88%
3-mo -25.32%
6-mo -32.95%
1-year -11.74%
3-year -60.40%
5-year -48.25%
YTD 18.00%
2022 -50.50%
2021 -25.74%
2020 -40.09%
2019 281.51%
2018 -48.71%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6204 seconds.